FFF
Freenome, Inc.
No trades
No trades
Compare with Freenome, Inc.
−0.07 USD
837.47 K USD
0.00 USD
76.17 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Aaron Elliott
Website
Headquarters
Brisbane
Founded
2014
ISIN
US35661P1003
CUSIP
35661P100
FIGI
BBG01N0FG6L0
Identifiers
ISIN US35661P1003
Freenome, Inc. operates as an early detection company, which engages in the development of blood-based screening tests to detect cancer. Its proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. The company was founded by Riley Ennis in 2014 and is headquartered in Brisbane, CA.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of FRNM is 15.81 USD — it has decreased by −1.37% in the past 24 hours. Watch Freenome, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Freenome, Inc. stocks are traded under the ticker FRNM.
FRNM stock has risen by 0.19% compared to the previous week, the month change is a −5.56% fall, over the last year Freenome, Inc. has showed a 49.15% increase.
We've gathered analysts' opinions on Freenome, Inc. future price: according to them, FRNM price has a max estimate of 21.00 USD and a min estimate of 17.00 USD. Watch FRNM chart and read a more detailed Freenome, Inc. stock forecast: see what analysts think of Freenome, Inc. and suggest that you do with its stocks.
FRNM reached its all-time high on Sep 21, 2026 with the price of 17.50 USD, and its all-time low was 9.95 USD and was reached on Jul 13, 2026. View more price dynamics on FRNM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FRNM stock is 6.72% volatile and has beta coefficient of 0.05. Track Freenome, Inc. stock price on the chart and check out the list of the most volatile stocks — is Freenome, Inc. there?
Today Freenome, Inc. has the market capitalization of 1.70 B, it has increased by 3.87% over the last week.
Yes, you can track Freenome, Inc. financials in yearly and quarterly reports right on TradingView.
Freenome, Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
FRNM earnings for the last quarter are −1.91 USD per share, whereas the estimation was −1.77 USD resulting in a −7.61% surprise. The estimated earnings for the next quarter are 0.14 USD per share. See more details about Freenome, Inc. earnings.
Freenome, Inc. revenue for the last quarter amounts to 3.20 M USD, despite the estimated figure of 3.02 M USD. In the next quarter, revenue is expected to reach 84.94 M USD.
FRNM net income for the last quarter is −114.94 K USD, while the quarter before that showed −51.75 K USD of net income which accounts for 0.00% change. Track more Freenome, Inc. financial stats to get the full picture.
No, FRNM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 9, 2026, the company has 3 employees. See our rating of the largest employees — is Freenome, Inc. on this list?
Like other stocks, FRNM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Freenome, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Freenome, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Freenome, Inc. stock shows the buy signal. See more of Freenome, Inc. technicals for a more comprehensive analysis.